Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  56,291 results for ""BISPECIFIC antibodies""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA-Approved Bispecific Antibodies in Oncology.

  • Authors : Lim K; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.; Zhu XS

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/administration & dosage

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Aug; Vol. 116 (2), pp. 315-327. Date of Electronic Publication: 2024 Jun 02.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

Bispecific antibodies for multiple myeloma: past, present and future.

  • Authors : Ochi T; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, Ehime, 791-0295, Japan. .; Division of Immune Regulation, Proteo-Science Center, Ehime University, Toon, Ehime, 791-0295, Japan. .

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/immunology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use

  • Source: International journal of hematology [Int J Hematol] 2024 Jul; Vol. 120 (1), pp. 23-33. Date of Electronic Publication: 2024 Apr 13.Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies.

  • Authors : Al Hadidi S; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Heslop HE

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/immunology

  • Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Aug 07; Vol. 32 (8), pp. 2444-2460. Date of Electronic Publication: 2024 May 31.Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Current landscape of CD3 bispecific antibodies in hematologic malignancies.

  • Authors : Kassner J; Department of Internal Medicine, New York Presbyterian/Weill Cornell Medical Center, New York, NY, USA; Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/immunology

  • Source: Trends in cancer [Trends Cancer] 2024 Aug; Vol. 10 (8), pp. 708-732. Date of Electronic Publication: 2024 Jul 10.Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Development of a platform method for rapid detection and characterization of domain-specific post-translational modifications in bispecific antibodies.

  • Authors : Liu S; Protein Biochemistry, Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, United States.; Nguyen JB

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/immunology ; Protein Processing, Post-Translational* ; Isoelectric Focusing*/Isoelectric Focusing*/Isoelectric Focusing*/methods

  • Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Jul 15; Vol. 244, pp. 116120. Date of Electronic Publication: 2024 Mar 18.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this?

  • Authors : Martino M; Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Reggio Calabria, Italy.; Gamberi B

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects

  • Source: Expert review of hematology [Expert Rev Hematol] 2024 Jul; Vol. 17 (7), pp. 375-390. Date of Electronic Publication: 2024 May 21.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Investigational bispecific antibodies for the treatment of rheumatoid arthritis.

  • Authors : Venetsanopoulou AI; Department of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.; Voulgari PV

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/administration & dosage ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/adverse effects

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2024 Jul; Vol. 33 (7), pp. 661-670. Date of Electronic Publication: 2024 May 08.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1.

  • Authors : Xu J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.; Laboratory of Lymphocyte Nuclear Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, 20892, USA.

Subjects: HIV-1*/HIV-1*/HIV-1*/immunology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/immunology ; Camelids, New World*/Camelids, New World*/Camelids, New World*/immunology

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Jul; Vol. 11 (26), pp. e2309268. Date of Electronic Publication: 2024 May 05.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

Read More Add to Saved list
×
Academic Journal

Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors.

  • Authors : Liu J; Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.; Zhu J

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Sep 10; Vol. 138, pp. 112609. Date of Electronic Publication: 2024 Jul 06.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Therapeutic potential of cis-targeting bispecific antibodies.

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/pharmacology ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/chemistry ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/immunology

  • Source: Cell chemical biology [Cell Chem Biol] 2024 Aug 15; Vol. 31 (8), pp. 1473-1489. Date of Electronic Publication: 2024 Aug 06.Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  56,291 results for ""BISPECIFIC antibodies""